CTNNB1 and cancer: A comprehensive characterization of CISD2 in 20 malignancies revealed significant associations with cancer-related pathways (WNT-beta-catenin signaling, TNFA signaling through NFKB, TGF-beta signature, etc.), and oxidative metabolism-associated pathways (xenobiotic metabolism, reactive oxygen species pathway).